Latest filing published 29 Apr 2013 for Obagi Medical Products, Inc., €350k.
No signal scores available.
Filings by Edward A. Grant span 2 companies, the busiest being Obagi Medical Products, Inc. and Merisel Inc /DE/. We count 12 filings; the first trade dates from 13 December 2006 and the latest from 25 April 2013.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 29 April 2013 came the latest disclosure, a transaction for €41k in Obagi Medical Products, Inc. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations